RHUMBLINE ADVISERS

Position in BDRX — Biodexa Pharmaceuticals Plc

CIK 1115418 BOSTON, MA

Position in BDRX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$11

-$43 QoQ

Shares Held

-20.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,189,862,874 across 287 Biotechnology names. BDRX ranks #274 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	423,140	$188,948,935
2	REGN	Regeneron Pharmaceuticals, Inc.	157,781	$121,907,911
3	INCY	Incyte Corp	693,665	$65,287,749
4	ALNY	Alnylam Pharmaceuticals, Inc.	195,277	$64,611,300
5	INSM	INSMED Inc	272,615	$44,578,004
6	JAZZ	Jazz Pharmaceuticals plc	164,542	$31,106,665
7	EXEL	Exelixis, Inc.	723,931	$31,049,400
8	ROIV	Roivant Sciences Ltd.	1,113,266	$30,837,468

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11	19	-20.8%	Shares	Sole	2026-05-12
2025-12-31	$54	24	+380.0%	Shares	Sole	2026-02-13
2025-09-30	$33	5	-92.8%	Shares	Sole	2025-11-06
2025-06-30	$59	69	-78.1%	Shares	Sole	2025-08-12
2025-03-31	$415	315	+104.5%	Shares	Sole	2025-05-29
2024-12-31	$623	154	-97.4%	Shares	Sole	2025-05-29
2024-09-30	$1,702	6,038	+122.8%	Shares	Sole	2024-11-12
2024-06-30	$2,428	2,710	+444.2%	Shares	Sole	2024-08-01
2024-03-31	$806	498	0.0%	Shares	Sole	2024-05-09
2023-12-31	$1,334	498	+123.3%	Shares	Sole	2024-02-08
2023-09-30	$1,112	223	-90.6%	Shares	Sole	2023-11-09
2023-06-30	$163	2,370	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.